The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s43441-025-00774-2
Published Online: 2025-04-22
Published Print: 2025-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, Hanke
Patterson, Julie A.
Campbell, Jonathan D.
Text and Data Mining valid from 2025-04-22
Version of Record valid from 2025-04-22
Article History
Received: 21 January 2025
Accepted: 4 April 2025
First Online: 22 April 2025
Declarations
:
: HZ, JP, and JC are employees of the National Pharmaceutical Council.